US approves Emergent’s smallpox vaccine for people at high risk of mpox
To address the mpox infection, the US Food and Drug Administration (FDA) has approved the expanded use of Emergent BioSolutions’ ACAM2000 smallpox vaccine to include individuals at high risk for …
US approves Emergent’s smallpox vaccine for people at high risk of mpox Read More